• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于模型简化的启发式机器类比方法的开发及其在Gi/Gs信号传导大规模模型中的应用

Development of a Heuristic Machine Analogy Method for Model Simplification With an Application to a Large-Scale Model of Gi/Gs Signaling.

作者信息

Yang Liang, Finlay David, Glass Michelle, Duffull Stephen

机构信息

Department of Pharmacy, Uppsala University, Uppsala, Sweden.

Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2025 Jun;14(6):1098-1107. doi: 10.1002/psp4.70029. Epub 2025 Apr 22.

DOI:10.1002/psp4.70029
PMID:40263755
Abstract

Model simplification is a process to simplify large-scale mathematical models to enable easy applications such as simulation and parameter estimation. A novel heuristic machine analogy method of model simplification was developed and applied to a motivating example of a model for cAMP signaling switch induced by Gi/Gs pathway competition for the CB receptor (consisting of 31 species and 76 parameters) to enable its use in estimation. The method first acquired an understanding of the mechanism by full model simulation, and then the mechanism was abstracted to a machine analogy. The machine analogy included signal start, signal mode selector, signal size regulator, and final effector, representing functions of different parts of the full model. The simplified minimal model (consisting of 11 species and 13 estimated parameters) was used for parameter estimation for Gi/Gs signaling of six CB agonists. The results of the minimal model suggested that six CB agonists have similar ratios of Gi/Gs activation, indicating Gi/Gs preference was more of a system effect rather than a ligand-specific effect. In conclusion, the novel machine analogy method can be used to heuristically simplify a larger-scale model while maintaining the important mechanisms. In the example here, the full Gi/Gs model of CB was successfully simplified, and the results indicated Gi/Gs preference is a system-dependent effect.

摘要

模型简化是一个简化大规模数学模型的过程,以实现诸如模拟和参数估计等易于应用的操作。一种新颖的启发式机器类比模型简化方法被开发出来,并应用于一个由Gi/Gs途径竞争CB受体诱导的cAMP信号开关模型(由31种物质和76个参数组成)的激励示例中,以使其可用于估计。该方法首先通过全模型模拟来理解机制,然后将该机制抽象为机器类比。机器类比包括信号起始、信号模式选择器、信号大小调节器和最终效应器,代表全模型不同部分的功能。简化后的最小模型(由11种物质和13个估计参数组成)用于六种CB激动剂的Gi/Gs信号参数估计。最小模型的结果表明,六种CB激动剂具有相似的Gi/Gs激活比率,表明Gi/Gs偏好更多是一种系统效应而非配体特异性效应。总之,这种新颖的机器类比方法可用于启发式地简化更大规模的模型,同时保留重要机制。在此示例中,CB的完整Gi/Gs模型成功简化,结果表明Gi/Gs偏好是一种依赖于系统的效应。

相似文献

1
Development of a Heuristic Machine Analogy Method for Model Simplification With an Application to a Large-Scale Model of Gi/Gs Signaling.一种用于模型简化的启发式机器类比方法的开发及其在Gi/Gs信号传导大规模模型中的应用
CPT Pharmacometrics Syst Pharmacol. 2025 Jun;14(6):1098-1107. doi: 10.1002/psp4.70029. Epub 2025 Apr 22.
2
CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.CB1 大麻素受体介导的环磷酸腺苷积累增加与 Gi/o 功能降低相关。
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):311-22. doi: 10.1515/jbcpp-2015-0096.
3
A quantitative pharmacology model for cannabinoid CB receptor mediated by Gi/Gs protein competition.大麻素 CB 受体通过 Gi/Gs 蛋白竞争介导的定量药理学模型。
Br J Pharmacol. 2024 Apr;181(8):1324-1340. doi: 10.1111/bph.16293. Epub 2024 Jan 12.
4
Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.大麻素激动剂对AP-1和CRE驱动转录的差异调节强调了CB1受体的功能选择性。
Br J Pharmacol. 2008 Sep;155(1):24-33. doi: 10.1038/bjp.2008.230. Epub 2008 Jun 9.
5
Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease.量化细胞信号传导和GPCR受体配体偏向性的方法:针对亨廷顿舞蹈病中内源性大麻素受体的药物特性
Methods Mol Biol. 2018;1780:549-571. doi: 10.1007/978-1-4939-7825-0_25.
6
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB, CB and CB/CB heteromer receptors.大麻素 CB、CB 和 CB/CB 杂二聚体受体作用的大麻二酚和大麻萜酚型植物大麻素的药理学数据。
Pharmacol Res. 2020 Sep;159:104940. doi: 10.1016/j.phrs.2020.104940. Epub 2020 May 26.
7
Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA.轴突 CB1 受体通过 cAMP 增加和 PKA 介导抑制性终末形成。
J Neurosci. 2021 Oct 6;41(40):8279-8296. doi: 10.1523/JNEUROSCI.0851-21.2021. Epub 2021 Aug 19.
8
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.大麻素CB1受体和多巴胺D2受体的同时刺激增强纹状体神经元中的环磷酸腺苷(cAMP)积累:Gs与CB1受体相连的证据
J Neurosci. 1997 Jul 15;17(14):5327-33. doi: 10.1523/JNEUROSCI.17-14-05327.1997.
9
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.信号大麻素受体 1- 蛋白复合物的结构。
Cell. 2019 Jan 24;176(3):448-458.e12. doi: 10.1016/j.cell.2018.11.040. Epub 2019 Jan 10.
10
Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.大麻素CB1受体第三个细胞内环的羧基末端参与Gs的组成性激活。
J Neurochem. 1999 May;72(5):2032-8. doi: 10.1046/j.1471-4159.1999.0722032.x.

本文引用的文献

1
A quantitative pharmacology model for cannabinoid CB receptor mediated by Gi/Gs protein competition.大麻素 CB 受体通过 Gi/Gs 蛋白竞争介导的定量药理学模型。
Br J Pharmacol. 2024 Apr;181(8):1324-1340. doi: 10.1111/bph.16293. Epub 2024 Jan 12.
2
The machine-organism relation revisited.重新审视机器-生物体关系。
Hist Philos Life Sci. 2023 Jul 13;45(3):34. doi: 10.1007/s40656-023-00587-2.
3
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor.μ-阿片受体 G 蛋白偏向性激动剂的关键性评估。
Trends Pharmacol Sci. 2020 Dec;41(12):947-959. doi: 10.1016/j.tips.2020.09.009. Epub 2020 Oct 20.
4
A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.临床药理学中定量系统药理学模型简化框架
Br J Clin Pharmacol. 2022 Feb;88(4):1430-1440. doi: 10.1111/bcp.14451. Epub 2020 Jul 14.
5
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.对G蛋白激活的内在效力较低可以解释新型阿片类激动剂改善的副作用情况。
Sci Signal. 2020 Mar 31;13(625):eaaz3140. doi: 10.1126/scisignal.aaz3140.
6
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.新型合成阿片类药物在μ阿片受体的结构-活性关系和偏激动剂评估:使用新型稳定的生物测定平台。
Biochem Pharmacol. 2020 Jul;177:113910. doi: 10.1016/j.bcp.2020.113910. Epub 2020 Mar 14.
7
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART.CD3 双特异性分子的转化定量系统药理学模型:应用于量化 P-钙黏蛋白 LP DART 介导的 T 细胞杀伤肿瘤细胞。
AAPS J. 2019 May 22;21(4):66. doi: 10.1208/s12248-019-0332-z.
8
Gα signalling of the CB receptor and the influence of receptor number.大麻素受体的Gα信号传导及受体数量的影响。
Br J Pharmacol. 2017 Aug;174(15):2545-2562. doi: 10.1111/bph.13866. Epub 2017 Jun 19.
9
Focus Issue: New insights in GPCR to G protein signaling.专刊主题:G 蛋白偶联受体(GPCR)到 G 蛋白信号转导的新见解。
Sci Signal. 2016 Apr 12;9(423):eg6. doi: 10.1126/scisignal.aaf7642.
10
Signalling bias in new drug discovery: detection, quantification and therapeutic impact.新药发现中的信号偏倚:检测、定量和治疗影响。
Nat Rev Drug Discov. 2013 Mar;12(3):205-16. doi: 10.1038/nrd3954. Epub 2012 Feb 15.